AMRX · TickerCove

AMRXAmneal Pharmaceuticals, Inc.Healthcare · Drug Manufacturers - Specialty & Genericas of 2026-09-16

Horizon

Issued 2026-09-16 at $18.08 · now $18.08 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, AMRX has typically landed between $14.64 and $22.78 — a range of −19.0% to +26.0% from the issuance price $18.08.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.

Actual close
Typical path (median)
Middle 50% of outcomes
90% range

4,422 overlapping 1 month windows · 2009-01-15 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($18.08) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

52-week range$18.08 · 89% of range

$9.6 low$19.1 high

Trailing 52 weeks to 2026-09-16 — factual context, not a signal.

Base rate up · monthiClimatology base rate that a US-listed stock rises over a month, with its 90% CI and ≈1,408 effective observations. Not a call on this stock — we have no evidence its odds differ.

53.9%

90% CI 51.7%–56.1%

Distribution · month iiThe price-anchored range: typical move (median), and the p90 downside/upside — 90% of similar periods stayed inside these. Ranges, not a prediction of direction.

+3.0%

typical move · IQR 16.1%

−19.0%worst (p90)+26.0%best (p90)

Insider convictioniOpen-market common-stock purchases by company insiders in the last 90 days (grants and option exercises excluded). Historical tendency, not advice — detail below.

conviction buys

0 open-market sales

Congress disclosuresiRecent disclosed congressional trades for this company. Purchase clusters (≥2 members buying within 90 days) historically preceded a modestly higher forward return (+32 bp/mo in 2022–2026, +45 bp/mo in 2015–2021) — a descriptive tendency, not a forecast input. Detail below.

0 buys · 0 sells · 0 members

cluster tilt persisted, ~halved after 2021

Where AMRX has typically landed a month from the 2026-09-16 close of $18.08 — the range is history, not a prediction.

now $18.08 (+0.0%)
typical $18.62 (+3.0%)
middle 50% $17.16–$20.07
90% range $14.64–$22.78

Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 4,422 windows spanning 2009-01-15 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.

Start	Return	Max drop	Max rise
3 worst
2019-07-09	−57.3%	−57.3%	+0.0%
2019-07-08	−55.6%	−55.6%	+1.0%
2019-07-05	−54.7%	−54.7%	+2.3%
3 best
2019-11-14	+105.2%	+0.0%	+105.2%
2019-11-15	+86.9%	+0.0%	+102.2%
2019-11-12	+86.7%	+0.0%	+86.7%

4,422 overlapping windows · 2009-01-15 – 2026-09-16 · not cherry-picked

Seasonality · by month i

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~18 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.

Jan

41%

+0.6%

n=17

Feb

72%

+5.3%

n=18

Mar

44%

−0.7%

n=18

Apr

56%

+1.9%

n=18

May

72%

+3.9%

n=18

Jun

39%

+0.6%

n=18

Jul

61%

−0.1%

n=18

Aug

50%

−0.1%

n=18

Sep

44%

+0.9%

n=18

Oct

53%

−0.7%

n=17

Nov

53%

+4.5%

n=17

Dec

59%

+4.4%

n=17

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Date	Person	Role	Action	Shares @ price	Value	Ownership Δ	vs S&P 1m	vs S&P 6m	Owned after	Filing
2026-08-13	Kiely John	director	Sale	50,000 @ $17.64	$882K	−19.2% of holding	+1.9%	not yet — horizon still open	210,252	Form 4 · filed 1 day after the trade
2026-08-12	Daly Jason B.	officer	Sale	210,000 @ $17.40	$3.7M	−85.7% of holding	−2.6%	not yet — horizon still open	35,171	Form 4 · filed 1 day after the trade
2026-08-12	Shah Nikita	officer	Sale	146,403 @ $17.51	$2.6M	−36.6% of holding	−2.6%	not yet — horizon still open	253,390	Form 4 · filed 1 day after the trade
2026-08-11	Daly Jason B.	officer	Sale	6,613 @ $17.70	$117K	−2.6% of holding	+0.3%	not yet — horizon still open	245,171	Form 4 · filed 2 days after the trade
2026-05-11	Autor Deborah M.	director	Sale	34,819 @ $12.94	$451K	−27.1% of holding	+21.8%	not yet — horizon still open	93,660	Form 4 · filed 1 day after the trade
2025-11-17	Nark Ted C	director	Sale	50,000 @ $11.72	$586K	−14.7% of holding	+5.6%	−6.4%	291,029	Form 4 · filed 2 days after the trade
2025-11-12	Shah Nikita	officer	Sale	131,856 @ $11.92	$1.6M	−47.4% of holding	+2.8%	−8.5%	146,403	Form 4 · filed 2 days after the trade
2025-08-27	Kiely John	director	Sale	32,000 @ $9.23	$295K	−12.4% of holding	+1.5%	+40.8%	225,433	Form 4 · filed 1 day after the trade
2025-08-25	Shah Nikita	officer	Sale	6,340 @ $9.50	$60K	−4.2% of holding	+1.4%	+48.6%	146,403	Form 4 · filed same day
2025-08-22	Shah Nikita	officer	Sale	114,492 @ $9.66	$1.1M	−42.8% of holding	−0.5%	+45.7%	152,743	Form 4 · filed 3 days after the trade
2025-08-20	BOYER ANDREW S	officer	Sale	279,244 @ $9.38	$2.6M	−64.7% of holding	−0.0%	+45.4%	152,426	Form 4 · filed 2 days after the trade
2025-08-15	Konidaris Tasos	officer	Sale	219,159 @ $9.43	$2.1M	−64.2% of holding	+0.5%	+54.0%	122,152	Form 4 · filed same day
2025-08-14	Konidaris Tasos	officer	Sale	119,206 @ $9.30	$1.1M	−25.9% of holding	+1.8%	+51.5%	341,311	Form 4 · filed 1 day after the trade
2025-08-14	Shah Nikita	officer	Sale	71,694 @ $9.29	$666K	−21.2% of holding	+1.8%	+51.5%	267,235	Form 4 · filed 1 day after the trade
2025-08-13	Konidaris Tasos	officer	Sale	161,365 @ $9.22	$1.5M	−25.9% of holding	+4.4%	+49.4%	460,517	Form 4 · filed 2 days after the trade
2025-08-12	Shah Nikita	officer	Sale	50,000 @ $9.04	$452K	−12.9% of holding	+9.5%	+54.7%	338,929	Form 4 · filed 1 day after the trade
2025-08-12	BOYER ANDREW S	officer	Sale	33,436 @ $9.05	$303K	−11.5% of holding	+9.5%	+54.7%	256,670	Form 4 · filed 1 day after the trade
2025-08-12	Daly Jason B.	officer	Sale	22,000 @ $9.05	$199K	−67.5% of holding	+9.5%	+54.7%	10,606	Form 4 · filed 1 day after the trade
2025-06-16	Patel Gautam	director	Sale	94,906 @ $8.02	$761K	−5.6% of holding	−2.9%	+40.0%	1,609,144	Form 4 · filed 2 days after the trade
2025-06-10	Patel Gautam	director	Sale	56,426 @ $8.02	$453K	−3.2% of holding	+2.9%	+39.4%	1,704,050	Form 4 · filed 2 days after the trade
2025-05-16	Shah Nikita	officer	Sale	49,140 @ $7.58	$372K	−11.2% of holding	+3.4%	+39.4%	388,929	Form 4 · filed 3 days after the trade
2025-05-12	Kiely John	director	Sale	50,000 @ $7.59	$380K	−16.3% of holding	−0.8%	+33.5%	257,433	Form 4 · filed 1 day after the trade
2025-05-05	Patel Gautam	director	Sale	4,900 @ $8.00	$39K	−0.3% of holding	−10.1%	+26.6%	1,720,218	Form 4 · filed 1 day after the trade
2025-05-02	Patel Gautam	director	Sale	3,768 @ $8.00	$30K	−0.2% of holding	−11.7%	+14.7%	1,725,118	Form 4 · filed 4 days after the trade
2025-04-01	Patel Gautam	director	Sale	80,000 @ $8.30	$664K	−4.4% of holding	−5.5%	+6.3%	1,728,886	Form 4 · filed 1 day after the trade
2025-03-14	Patel Tushar Bhikhubhai	tenPercentOwner	Sale	5,000,000 @ $8.35	$41.8M	−9.3% of holding	−13.7%	−6.2%	48,578,209	Form 4 · filed 3 days after the trade
2025-03-06	Daly Jason B.	officer	Sale	46,936 @ $8.73	$410K	−59.0% of holding	−4.2%	−3.9%	32,606	Form 4 · filed 1 day after the trade
2025-03-05	BOYER ANDREW S	officer	Sale	125,000 @ $8.89	$1.1M	−30.1% of holding	−5.3%	−5.5%	290,106	Form 4 · filed 2 days after the trade
2025-03-05	Konidaris Tasos	officer	Sale	100,000 @ $8.91	$891K	−13.9% of holding	−5.3%	−5.5%	621,882	Form 4 · filed 2 days after the trade
2025-03-05	Alva Emily Peterson	director	Sale	80,000 @ $8.90	$712K	−31.9% of holding	−5.3%	−5.5%	170,771	Form 4 · filed 2 days after the trade
2025-03-05	Daly Jason B.	officer	Sale	43,064 @ $8.88	$382K	−35.1% of holding	−5.3%	−5.5%	79,542	Form 4 · filed 2 days after the trade
2025-03-03	Patel Gautam	director	Sale	80,000 @ $8.90	$712K	−4.2% of holding	−2.4%	−1.0%	1,808,886	Form 4 · filed 2 days after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

268 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

Date	Person	Role	Action	Shares	Owned after	Filing
2026-09-11	BUCHI J KEVIN	director	Option exercise	20,445	95,522	Form 4
2026-09-11	BUCHI J KEVIN	director	Option exercise	20,445	0	Form 4
2026-09-01	BOYER ANDREW S	officer	Gift	80,000	193,646	Form 4
2026-08-21	BOYER ANDREW S	officer	Gift	152,426	273,646	Form 4
2026-08-13	Kiely John	director	Gift	10,000	200,252	Form 4
2026-08-11	BUCHI J KEVIN	director	Option exercise	168,573	93,499	Form 4
2026-08-10	Patel Tushar Bhikhubhai	tenPercentOwner	Award / grant	12,763,469	61,341,678	Form 4
2026-08-10	Patel Gautam	director	Award / grant	283,632	283,632	Form 4
2026-08-10	Patel Chirag K.	director	Award / grant	6,381,734	6,381,734	Form 4
2026-08-10	Patel Tushar Bhikhubhai	tenPercentOwner	Award / grant	12,763,469	61,341,678	Form 4
2026-08-10	Patel Chirag K.	director	Award / grant	6,381,734	6,381,734	Form 4
2026-08-10	Patel Gautam	director	Award / grant	283,632	283,632	Form 4
2026-08-10	Patel Chintu	director	Award / grant	6,381,734	6,381,734	Form 4
2026-08-10	Patel Chintu	director	Award / grant	6,381,734	6,381,734	Form 4
2026-05-07	MEISTER PAUL M	director	Option exercise	48,747	0	Form 4
2026-05-07	Nark Ted C	director	Option exercise	34,819	0	Form 4
2026-05-07	Autor Deborah M.	director	Option exercise	34,819	0	Form 4
2026-05-07	Yanai Shlomo	director	Option exercise	34,819	0	Form 4
2026-05-07	George Jeffrey P.	director	Option exercise	34,819	0	Form 4
2026-05-07	Kiely John	director	Option exercise	34,819	0	Form 4
2026-05-07	BUCHI J KEVIN	director	Option exercise	34,819	0	Form 4
2026-05-07	Patel Gautam	director	Option exercise	34,819	0	Form 4
2026-05-07	Autor Deborah M.	director	Option exercise	34,819	128,479	Form 4
2026-05-07	Kiely John	director	Option exercise	34,819	260,252	Form 4
2026-05-07	Yanai Shlomo	director	Option exercise	34,819	320,804	Form 4
2026-05-07	MEISTER PAUL M	director	Option exercise	48,747	832,800	Form 4
2026-05-07	BUCHI J KEVIN	director	Option exercise	34,819	75,077	Form 4
2026-05-07	George Jeffrey P.	director	Option exercise	34,819	344,614	Form 4
2026-05-07	Patel Gautam	director	Option exercise	34,819	1,643,963	Form 4
2026-05-07	Kiely John	director	Option exercise	34,819	260,252	Form 4
2026-05-07	Patel Gautam	director	Option exercise	34,819	1,643,963	Form 4
2026-05-07	George Jeffrey P.	director	Option exercise	34,819	344,614	Form 4
2026-05-07	Autor Deborah M.	director	Option exercise	34,819	128,479	Form 4
2026-05-07	BUCHI J KEVIN	director	Option exercise	34,819	75,077	Form 4
2026-05-07	Nark Ted C	director	Option exercise	34,819	325,848	Form 4
2026-05-06	Autor Deborah M.	director	Award / grant	19,824	19,824	Form 4
2026-05-06	George Jeffrey P.	director	Award / grant	19,824	19,824	Form 4
2026-05-06	Patel Gautam	director	Award / grant	19,824	19,824	Form 4
2026-05-06	Kiely John	director	Award / grant	19,824	19,824	Form 4
2026-05-06	BUCHI J KEVIN	director	Award / grant	19,824	19,824	Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Resolves in i

28d remaining

2026-09-173% elapsed2026-10-15

Logged immutably 2026-09-17; scored automatically on 2026-10-15 — no edits, ever.

Earnings & context analysis

These panels are being prepared. They are generated by multiple language models, checked, and stored before display — never written live for a page view. Until a model panel has been generated and reviewed for a company, nothing is shown here, honestly, rather than a placeholder.

Calibration i

Every forecast is logged when made and scored when the month is up. The record is shown from the day it starts — young and honest.

How scoring works →

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

Reported insider & political trades

Congressional disclosures

Seasonality · by month i